Update on the genetics of nonbacterial osteomyelitis in humansCox, Allison J.; Ferguson, Polly J.Current Opinion in Rheumatology: September 2018 - Volume 30 - Issue 5 - p 521–525 doi: 10.1097/BOR.0000000000000530 PEDIATRIC AND HERITABLE DISORDERS: Edited by Polly J. Ferguson Abstract Author InformationAuthors Article MetricsMetrics Purpose of review To summarize the current advances in our understanding or the genetic basis of nonbacterial osteomyelitis. Recent findings Chronic recurrent multifocal osteomyelitis (CRMO) is a complex genetic disorder. Past discoveries identified several single gene defects (LPIN2, Pstpip2 and IL1RN) that cause IL-1-mediated sterile multifocal osteomyelitis. Recently Lorden et al.'s studies show that LIPIN2 deficiency can activate the NLRP3 inflammasome through alterations in the function of P2X7 receptor providing evidence that Majeed syndrome is an NLRP3 inflammasomopathy. New gene discoveries include the identification of FBLIM1 as a CRMO susceptibility gene. Mutations in FBLIM1 were found in a consanguineous family with CRMO. Fblim1 is one of the most significantly differentially expressed gene in bone from chronic multifocal osteomyelitis (cmo) mice, plays a role in IL-10-driven anti-inflammatory responses, and is involved in the physiology of bone remodeling. Lastly, new data on the putative CRMO susceptibility locus on chromosome 18 is presented here. Using Sanger sequencing, rather than microsatellite analysis, the DS18S60 susceptibility region could not be replicated in a larger cohort. Summary CRMO occurs in humans, nonhuman primates, dogs and mice. There is a genetic component to disease but the genetic basis has only been identified for a small percentage of all cases. Division of Pediatric Rheumatology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA Correspondence to Dr Polly J. Ferguson, MD, Division of Pediatric Rheumatology, University of Iowa Carver College of Medicine, 200 Hawkins Drive, 4038 Boyd Tower, Iowa City, IA 52242, USA. Tel: +1 319 467 5111; fax: +1 319 356 2341; e-mail: email@example.com Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.co-rheumatology.com). Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.